Evidence map›Paper›PMID 24671554›Full record

ArticleClinical and vaccine immunology : CVI2014

Activation of innate immune responses by Haemophilus influenzae lipooligosaccharide.

Joshua Choi, Andrew D Cox, Jianjun Li, William McCready, Marina Ulanova

Open access · diamondAbstract read
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Immunological efficiency ofIranian journal of microbiology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Phosphocholine-Modified Lipooligosaccharides ofMolecules (Basel, Switzerland) · 2018
    Article
  11. MLVA typing ofIranian journal of microbiology · 2018
    Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Joshua ChoiDepartment of Biology, Lakehead University, Thunder Bay, Ontario, Canada.
Andrew D Cox
Jianjun Li
William McCready
Marina Ulanova
Lakehead University · CANational Research Council Canada · CANOSM University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A Gram-negative pathogen Haemophilus influenzae has a truncated endotoxin known as lipooligosaccharide (LOS). Recent studies on H. influenzae LOS highlighted its structural and compositional implications for bacterial virulence; however, the role of LOS in the activation of innate and adaptive immunity is poorly understood. THP-1 monocytes were stimulated with either lipopolysaccharide (LPS) from Escherichia coli or LOS compounds derived from H. influenzae Eagan, Rd, and Rd lic1 lpsA strains. Cell surface expression of key antigen-presenting, costimulatory, and adhesion molecules, as well as gene expression of some cytokines and pattern recognition receptors, were studied. Eagan and Rd LOS had a lower capacity to induce the expression of ICAM-1, CD40, CD58, tumor necrosis factor alpha (TNF-α), and interleukin-1β (IL-1β) compared to LPS. In contrast, antigen-presenting (HLA-ABC or HLA-DR) and costimulatory (CD86) molecules and NOD2 were similarly upregulated in response to LOS and LPS. LOS from a mutant Rd strain (Rd lic1 lpsA) consistently induced higher expression of innate immune molecules than the wild-type LOS, suggesting the importance of phosphorylcholine and/or oligosaccharide extension in cellular responses to LOS. An LOS compound with a strong ability to upregulate antigen-presenting and costimulatory molecules combined with a low proinflammatory activity may be considered a vaccine candidate to immunize against H. influenzae.

Indexed as

Immunity, InnateAntigens, CDCell LineCytokinesEscherichia coliGene Expression ProfilingHaemophilus influenzaeHLA AntigensHumansIntercellular Adhesion Molecule-1LipopolysaccharidesMonocytesNod2 Signaling Adaptor ProteinReceptors, ImmunologicAntigens, CDCytokinesHLA AntigensIntercellular Adhesion Molecule-1lipid-linked oligosaccharidesLipopolysaccharidesNOD2 protein, humanNod2 Signaling Adaptor ProteinReceptors, Immunologic

Identifiers

PMID24671554
PMCPMC4018885
OpenAlexW2148673830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.